This protocol is judged by an institutional overview board, an unbiased group that reviews any scientific trials involving individuals. If a examine requires a Routine I drug, when the board approves the protocol as ethical, the researchers need to submit an application for an investigational new drug (IND) number within the FDA.Clients described